ClinicalTrials.gg
RecruitingNCT06829433MDOA&TKRUpdated Feb 21, 2025

Movement Dynamics of Knee Osteoarthritis and Total Knee Replacement

An observational study in Knee Osteoarthritis and Total Knee Replacement, sponsored by University of Portsmouth. Recruiting at 1 site in United Kingdom. Open to participants aged 40 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-21.

Sponsored by University of Portsmouth · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2026, 10 months ago, but the record still lists the study as recruiting.
  • Started May 2024; still recruiting 2 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-crossover
Time perspective
Cross-sectional
Enrollment
36
Ages
40 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 112 studies in Osteoarthritis, Knee with a site in United Kingdom — 12 open to participants now, 21 under way, none of them phase 3. Osteoarthritis, Knee · United Kingdom.

Planned enrollment
16th of 21
36 · median 150
Started
2024
with 4 others
Observational
21 of 112
3 open now
Primary completion
2026-01
later than 5 of 20 live
Registered
106th of 112
by date

Among the 112 studies in Osteoarthritis, Knee with a site in United Kingdom, this one is the 16th largest by planned enrollment of the 21 observational ones that give a count, is one of 5 that started in 2024, is one of 21 observational ones, reaches primary completion later than 5 of the 20 other live ones, and was the 106th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

12 of the 112 studies in Osteoarthritis, Knee with a site in United Kingdom are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 40 Years to 85 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 112 studies in Osteoarthritis, Knee with a site in United Kingdom, or all of them as a file.
02

Study summary

This research aims to explore differences in walking and functional movement mechanics, exercise response, and physical activity between people with osteoarthritis (OA), those who have undergone total joint replacement, and healthy individuals.

Read the detailed description

People living with OA tend to be less physically active than those without the disease, which is often due to pain, stiffness and joint instability. This reduction in physical activity can lead to additional health problems down the line. When the disease becomes severe, joint replacement surgeries are sometimes performed to relieve pain and improve individuals' quality of life. However, despite reducing pain, there is little evidence to show that joint replacement surgeries encourage individuals to return to healthy physical activity levels.

Reasons for the lack of change may include a failure to address unhealthy walking and movement patterns which could still be causing pain and instability and reduced physical fitness levels.

By investigating these reasons, we hope that findings from this study will help to inform future interventions that improve clinical outcomes and quality of life for individuals with OA and post-joint replacement.

03

Conditions studied

  • Knee Osteoarthritis
  • Total Knee Replacement
04

Who can participate

Ages eligible
40 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Local private physiotherapy clinics and local sports clubs

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed symptomatic bilateral or unilateral knee osteoarthritis, self-reported ability to walk without an aid for 10 minutes and to ascend and descend stairs, no neurological conditions or other musculoskeletal pathology/injury which would impact walking gait.

Exclusion criteria

Exclusion Criteria:

  • Unable to walk at 0.8 m/s, exclusion based on IMO screening, non-English speaking, lacking ability to consent.
05

Study design

Observational model
Case-crossover
Time perspective
Cross-sectional
Enrollment
36 participants (estimated)
Patient registry
No

Groups and cohorts

  • Total Knee Replacement

    Other: No intervention

  • Knee Osteoarthritis

    Other: No intervention

  • Asymptomatic Controls

    Other: No intervention

Interventions

  • OtherNo intervention

    Observational cross-sectional study

06

What researchers measure

Primary outcomes

  1. Peak knee adduction moment

    The external knee adduction moment (KAM), which reflects medial-to-lateral knee joint load distribution during gait, has become an OA treatment target. The peak KAM is a strong predictor of presence, severity, and the rate of progression of knee OA.

    Time frame: From the start of a biomechanical movement testing visit to the end (approximately 2 hours)

07

Study locations

1 of 1 sites recruiting
  • School of Psychology, Health and Sport Sciences, University of Portsmouth
    Portsmouth, Hampshire PO1 2ER, United Kingdom
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2024 (actual). Primary completion is estimated for Jan 2026, 20 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 28, 2025
First posted
Feb 17, 2025
StartActual
May 7, 2024
Primary completionEst.
Jan 2026
CompletionEst.
Sep 2026
Last update
Feb 21, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06829433
Lead sponsor
University of Portsmouth
Responsible party
Josie Morris (Principal Investigator, University of Portsmouth) — Principal investigator
First posted
Feb 17, 2025
Start date
May 7, 2024
Primary completion
Jan 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Feb 21, 2025

Study contacts

Josie Morris, BSc
Contact
josie.morris@port.ac.uk
02392 846395
Joseph Moore, PhD
Contact
joseph.moore@port.ac.uk

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion